Illustration: Aïda Amer/Axios

Given all the antitrust scrutiny being aimed at the tech giants, it can be surprising to see other monopolies operating — and even growing via acquisition — with few if any regulatory consequences.

Monopoly 1: EssilorLuxottica is a $50 billion eyewear giant that incorporates everything from lens manufacturers to dozens of brands such as Oakley, Ray-Ban, Varilux, LensCrafters and Pearle Vision. If your frames are from Chanel or Prada or Versace, they are EssilorLuxottica products.

  • The latest giant to be swept up into the EssilorLuxottica monopoly: GrandVision, a chain with more than 7,200 stores globally.
  • European antitrust regulators might force some divestments in France and Belgium, but either way, this deal will only serve to consolidate EssilorLuxottica's global monopoly.
  • Curiously, this $7.9 billion deal is being done while EssilorLuxottica is still searching for a new CEO.
"If the deal goes through, it would strengthen EssilorLuxottica’s ability to charge markups of as much as 1,000% for frames and lenses -- market power that comes from controlling all aspects of production, owning the country’s largest chain of glasses stores and operating a major insurance plan."
David Lazarus, LA Times

Monopoly 2: Surescripts manages about 80% of all prescriptions in America. It's owned by industry giants CVS and Express Scripts, and if your prescription is filled electronically, it's almost certainly filled by Surescripts. In the words of Amazon, Surescripts is "the sole clearinghouse for medication history in the United States."

  • Driving the news: CVS and Express Scripts are facing competition from PillPack, which is owned by Amazon. Now Surescripts won't give PillPack the information it needs to find out what medicines its customers have been prescribed.
  • The FTC is taking legal action against Surescripts, accusing it of forcing pharmacies to use its services. But that doesn't seem to be helping Amazon, whose PillPack product is a masterpiece of design that — by sending your pills in presorted packets that tell you when to ingest them — significantly increases the probability that patients will take all their pills as prescribed.

The bottom line: The world is full of anticompetitive monopolies, many of which operate in plain sight.

Go deeper: The monopolization of patient drug data

Go deeper

Updated 19 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 1:30 a.m. ET: 31,779,835 — Total deaths: 975,104 — Total recoveries: 21,890,442Map.
  2. U.S.: Total confirmed cases as of 1:30 a.m. ET: 6,933,548 — Total deaths: 201,884 — Total recoveries: 2,670,256 — Total tests: 97,459,742Map.
  3. Health: CDC director says over 90% of Americans have not yet been exposed to coronavirus — Supply shortages continue to plague testing.
  4. Politics: Missouri Gov. Mike Parson tests positive for coronavirus — Poll says 51% of Republicans trust Trump on coronavirus more than the CDC.
  5. Technology: The tech solutions of 2020 may be sapping our resolve to beat the coronavirus
  6. Vaccines: Johnson & Johnson begins large phase 3 trial — The FDA plans to toughen standards.
  7. Sports: Less travel is causing the NBA to see better basketball.
  8. Future: America's halfway coronavirus response

"Not enough": Protesters react to no murder charges in Breonna Taylor case

A grand jury on Wednesday indicted Brett Hankison, one of the Louisville police officers who entered Breonna Taylor's home in March, on three counts of wanton endangerment for firing shots blindly into neighboring apartments.

Details: Angering protesters, the grand jury did not indict any of the three officers involved in the botched drug raid on homicide or manslaughter charges related to the death of Taylor.

Two officers shot in Louisville amid Breonna Taylor protests

Police officers stand guard during a protest in Louisville, Kentucky. Photo: Ben Hendren/Anadolu Agency via Getty Images

Louisville Metro Police Department said two officers were shot downtown in the Kentucky city late Wednesday, just hours after a grand jury announced an indictment in the Breonna Taylor case.

Details: A police spokesperson told a press briefing a suspect was in custody and that the injuries of both officers were not life-threatening. One officer was "alert and stable" and the other was undergoing surgery, he said.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!